| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Adjusted EPS | $1.57 Q4 2025 (+0.6% YoY) | $1.75 Q1 2026 (+6.6% YoY excluding FX) | +$0.18 sequential acceleration |
| Japan Sales (Yen) | 15.7% growth Q4 2025 | 25.5% growth Q1 2026 | +980 bps acceleration |
| Japan Underlying Earned Premiums | -1.2% Q4 2025 | -1.3% Q1 2026 | -10 bps deterioration |
| Japan Benefit Ratio | 65.0% Q4 2025 | 62.9% Q1 2026 | -210 bps improvement |
| Japan Pretax Margin | 31.3% Q4 2025 | 35.0% Q1 2026 | +370 bps expansion |
| U.S. Net Earned Premiums | +4.0% Q4 2025 | +3.5% Q1 2026 | -50 bps deceleration |
| U.S. Benefit Ratio | 48.6% Q4 2025 | 47.2% Q1 2026 | -140 bps improvement |
| U.S. Pretax Margin | 17.4% Q4 2025 | 20.4% Q1 2026 | +300 bps expansion |
| ESR Capital Ratio | 253% with USP Q4 2025 | 243% with USP Q1 2026 | -1000 bps decline from subsidiary dividends |
| Share Repurchases | $800M Q4 2025 | $1.0B Q1 2026 | +$200M increase |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.